Cryo-Cell International Reports Q2 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04

Reuters07-16

Cryo-Cell International Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04

Cryo-Cell International Inc. (NYSE American LLC: CCEL), the pioneering private cord blood bank, has released its financial results for the fiscal second quarter ending May 31, 2025. The company reported revenues of $7.9 million, marking a slight decrease from $8.0 million in the same period of fiscal 2024. The revenue breakdown for the second quarter of 2025 included $7.87 million from processing and storage fees, $43,000 from public banking, and $14,000 from product sales, compared to $7.97 million, $41,000, and $36,000, respectively, in the previous year. Net income for the quarter stood at $356,000, or $0.04 per basic and diluted share, a decline from $656,000, or $0.08 per share, in the equivalent quarter of the prior year. The company did not provide any outlook or guidance in the current release.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250715194484) on July 15, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2551222192?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-16 05:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551222192","market":"fut","top_or_hot":-1,"title":"Cryo-Cell International Reports Q2 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Cryo-Cell International Reports <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Cryo-Cell International Inc. (NYSE American LLC: CCEL), the pioneering private cord blood bank, has released its financial results for the fiscal second quarter ending May 31, 2025. The company reported revenues of $7.9 million, marking a slight decrease from $8.0 million in the same period of fiscal 2024. The revenue breakdown for the second quarter of 2025 included $7.87 million from processing and storage fees, $43,000 from public banking, and $14,000 from product sales, compared to $7.97 million, $41,000, and $36,000, respectively, in the previous year. Net income for the quarter stood at $356,000, or $0.04 per basic and diluted share, a decline from $656,000, or $0.08 per share, in the equivalent quarter of the prior year. The company did not provide any outlook or guidance in the current release.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250715194484) on July 15, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cryo-Cell International Reports Q2 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCryo-Cell International Reports Q2 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-16 05:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Cryo-Cell International Reports <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Cryo-Cell International Inc. (NYSE American LLC: CCEL), the pioneering private cord blood bank, has released its financial results for the fiscal second quarter ending May 31, 2025. The company reported revenues of $7.9 million, marking a slight decrease from $8.0 million in the same period of fiscal 2024. The revenue breakdown for the second quarter of 2025 included $7.87 million from processing and storage fees, $43,000 from public banking, and $14,000 from product sales, compared to $7.97 million, $41,000, and $36,000, respectively, in the previous year. Net income for the quarter stood at $356,000, or $0.04 per basic and diluted share, a decline from $656,000, or $0.08 per share, in the equivalent quarter of the prior year. The company did not provide any outlook or guidance in the current release.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250715194484) on July 15, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICE","symbol_name":"洲际交易所","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDLbSSMzZ:1","article_id":"2551222192","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551222192","pubTimestamp":1752613227,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Cryo-Cell International Reports Q2 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire  on July 15, 2025, and is solely responsible for the information contained therein.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ICE":"洲际交易所","CCEL":"CRYO-CELL International, Inc."},"translate_title":"Cryo-Cell International报告2025年第二季度财务状况：收入小幅下降1%，净利润降至356,000美元，每股收益降至0.04美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CCEL":0.9,"ICE":0.9},"content_text":"Cryo-Cell International Reports Q2 2025 Financials: Revenue Slightly Down by 1%, Net Income Drops to $356,000, EPS Falls to $0.04\n    \n\n        Cryo-Cell International Inc. (NYSE American LLC: CCEL), the pioneering private cord blood bank, has released its financial results for the fiscal second quarter ending May 31, 2025. The company reported revenues of $7.9 million, marking a slight decrease from $8.0 million in the same period of fiscal 2024. The revenue breakdown for the second quarter of 2025 included $7.87 million from processing and storage fees, $43,000 from public banking, and $14,000 from product sales, compared to $7.97 million, $41,000, and $36,000, respectively, in the previous year. Net income for the quarter stood at $356,000, or $0.04 per basic and diluted share, a decline from $656,000, or $0.08 per share, in the equivalent quarter of the prior year. The company did not provide any outlook or guidance in the current release.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250715194484) on July 15, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551222192","isCrawlerRequest":true}